480TiPPhase 3, randomised, open-label study of durvalumab...

Annals of Oncology 2015 / 12 Vol. 26; Iss. suppl 9

480TiPPhase 3, randomised, open-label study of durvalumab (MEDI4736) in combination with tremelimumab versus platinum-based chemotherapy in first-line treatment of patients with advanced or metastatic NSCLC: NEPTUNE

Mok, T., Schmid, P., Arén, O., Arrieta, O., Gottfried, M., Jazieh, A.R., Ramlau, R., Timcheva, C., Martin, C., Zhao, L., McIntosh, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv532.64
Date:
December, 2015
File:
PDF, 36 KB
english, 2015
Conversion to is in progress
Conversion to is failed